Shares of Aphria dropped 4.82% to $12.44 at 12:50 EST on Thursday, following last session’s downward trend. NASDAQ Composite is rising 0.21% to $13,485.79, after two consecutive sessions in a row of gains. This seems, up to now, a somewhat positive trend trading session today.

Aphria’s last close was $13.07, 12.62% under its 52-week high of $14.01.

Volatility

Aphria’s last day, last week, and last month’s average volatility was a negative 4.13%, a positive 7.03%, and a positive 2.74%, respectively.

Aphria’s last day, last week, and last month’s high and low average amplitude percentage was 7.76%, 12.09%, and 7.60%, respectively.

Aphria’s Stock Yearly Top and Bottom Value

Aphria’s stock is valued at $12.44 at 12:50 EST, way under its 52-week high of $14.01 and way above its 52-week low of $1.95.

Aphria’s Moving Average

Aphria’s worth is way higher than its 50-day moving average of $8.55 and way above its 200-day moving average of $5.87.

Previous days news about Aphria

Aphria stock price target raised to c$15.50 by stifel but analysts caution on stretched valuation. According to MarketWatch on Tuesday, 19 January, "Shares of Canadian cannabis company Aphria Inc. rose 4.4% in premarket trade Tuesday, after Stifel raised its stock price target to C$15.50 ($12.18) from C$9.80, and has fallen 1% — following earnings and adding to postelection strength. ", "But we believe the robust valuation (11X EV/FY22E net cannabis revenue) serves as an impediment for material outperformance with the stock likely to remain volatile." Aphria shares have gained 136% in the last 12 months, while the Cannabis ETF has gained 29%."

Update: Aphria stock price target raised by stifel but analysts caution on stretched valuation. According to MarketWatch on Tuesday, 19 January, "Shares of Canadian cannabis company Aphria Inc. rose 4.4% in premarket trade Tuesday, after Stifel raised its stock price target to C$15.50 ($12.18) from C$9.80, and has fallen 1% — following earnings and adding to postelection strength. ", "But we believe the robust valuation (11X EV/FY22E net cannabis revenue) serves as an impediment for material outperformance with the stock likely to remain volatile." Cantor Fitzgerald raised its 12-month stock price target for Aphria to C$26 from C$11.75 on Friday, to has gained 29%."

LEAVE A REPLY

Please enter your comment!
Please enter your name here